20 articles
New technique combines your own cells with light therapy to supercharge mitochondria for dramatic skin regeneration and wound healing.
Scientists develop photoswitchable peptides that can be activated with light for precise drug delivery and targeted therapy.
A novel photoactivatable drug system uses NK immune cells to eliminate aging joint cells, reducing osteoarthritis progression in mice.
Rose stem cell exosomes enhanced wrinkle reduction and skin texture when combined with radiofrequency treatment in 6-month study.
Groundbreaking cellular therapy gets green light for human testing, potentially reversing aging at the cellular level.
A preclinical rat study finds pulsed electromagnetic field therapy applied remotely cuts fracture healing time from 30 to 23 days and eliminates post-surgical abscesses.
New combination therapy using stem cell exosomes and spirulina-based hydrogel shows promise for treating hard-to-heal diabetic wounds.
New technique enables researchers to study how proteins change shape when exposed to light, advancing structural biology research.
AAV gene therapy successfully restored retinal function and improved vision in rats with LRAT-associated retinitis pigmentosa.
A flexible PEMF coil patch delivers targeted electromagnetic stimulation to skin wounds, offering a tunable, non-invasive approach to chronic wound repair.
Comprehensive review reveals how PRP's growth factors, immune cells, and exosomes work together to enhance tissue repair across multiple medical specialties.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
New regenerative approaches using stem cells and biostimulatory compounds promise to restore skin function by targeting root causes of aging.
Tumor-infiltrating lymphocyte therapies are emerging as a powerful cancer treatment. Here's what the science says and why it matters for longevity.
Activating three Yamanaka factors — OCT4, SOX2, and KLF4 — appears to reverse epigenetic aging in human eye cells, marking a milestone in rejuvenation medicine.
A Phase 1/2 trial of NFS-02 gene therapy for LHON-associated vision loss was terminated before completion, raising questions about mitochondrial gene therapy.
Researchers developed topical CRISPR gene therapy that prevents sight-threatening blood vessel growth in injured corneas.
First successful gene therapy for aniridia increases retinal thickness and activates key vision pathways in mice.
New 'off-the-shelf' CAR-T therapy eliminated detectable lymphoma cells in over half of treated patients in early clinical data.
A new wave of antidepressants is targeting patients who don't respond to standard treatments, with implications for brain health and longevity.
